Madhav Channavazzala

Vantage Research, India

Poster(s):

• PII-212 - A QUANTITATIVE SYSTEMS PHARMACOLOGY (QSP) MODEL FOR PREDICTING EFFICACY FOR A COMBINATION OF AN ANTIBODY DRUG CONJUGATE (ADC) AND A CHECKPOINT INHIBITOR (CPI) IN PHASE II/III CLINICAL TRIALS
  Thursday, March 28, 2024

  5:00 PM – 6:30 PM MDT